Assyro AI

Orange Book product · Generic (ANDA)

MYCOPHENOLATE SODIUM

MYCOPHENOLATE SODIUM

Generic (ANDA)ANDA 214289DISCN TWI PHARMS
View MYCOPHENOLATE SODIUM familyOpen on FDA Orange Book

At a glance

Nov 03, 2021

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Nov 03, 2021

    4 yr 8 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

MYCOPHENOLATE SODIUM

Strength

EQ 180MG BASE

Dosage form

TABLET, DELAYED RELEASE

Route

ORAL

TE code

Not listed

Application

ANDA 214289

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of MYCOPHENOLATE SODIUM

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo